Clinical characteristics and antimicrobial susceptibility of Fusobacterium species isolated over 10 years at a Japanese university hospital.
Antibiotic susceptibility
Fusobacterium
Minimum inhibitory concentration
Solid organ malignancy
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
19 Dec 2023
19 Dec 2023
Historique:
received:
16
10
2023
accepted:
02
12
2023
medline:
19
12
2023
pubmed:
19
12
2023
entrez:
19
12
2023
Statut:
aheadofprint
Résumé
Anaerobic bacteria, existing on human skin and mucous membranes, can cause severe infections with complications or mortality. We examined the clinical characteristics of patients infected with Fusobacterium spp. and assessed their antibiotic susceptibility. Clinical data were collated from patients diagnosed with Fusobacterium infections in a Japanese university hospital between 2014 and 2023. Antibiotic susceptibility tests were conducted following the Clinical and Laboratory Standards Institute guidelines. We identified 299 Fusobacterium isolates. The median age was 61 years (range, 14-95 years), with females constituting 43.1% of the patients. Most infections were community-acquired (84.6%, 253/299). Multiple bacterial strains were isolated simultaneously in 74.6% of cases. One-fourth of the patients had solid organ malignancies (25.4%, 76/299), and 14.5% (11/76) of those had colorectal cancer. The 30-day mortality rate was 1.3%. Fusobacterium species were isolated from blood cultures in 6% (18/299) of the patients. Patients, aged 75 years or older, with cerebrovascular disease or hematologic malignancy exhibited significantly higher prevalence of blood culture isolates in univariate analysis. Each Fusobacterium species had its characteristic infection site. Approximately 5% F. nucleatum and F. necrophorum isolates showed penicillin G resistance. Moxifloxacin resistance was observed in varying degrees across strains, ranging from 4.6 to 100% of isolates. All isolates were sensitive to β-lactam/β-lactamase inhibitors, carbapenems, and metronidazole. We show a link between Fusobacterium species and solid organ malignancies. We observed resistance to penicillin, cefmetazole, clindamycin, and moxifloxacin, warranting caution in their clinical use. This study offers valuable insights for managing Fusobacterium infections and guiding empirical treatments.
Identifiants
pubmed: 38112966
doi: 10.1007/s10096-023-04734-2
pii: 10.1007/s10096-023-04734-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Centor RM, Atkinson TP, Xiao L (2022) Fusobacterium necrophorum oral infections - a need for guidance. Anaerobe 75:102532. https://doi.org/10.1016/j.anaerobe.2022.102532
doi: 10.1016/j.anaerobe.2022.102532
pubmed: 35122953
Chen Y, Huang Z, Tang Z, Huang Y, Huang M, Liu H, Ziebolz D, Schmalz G, Jia B, Zhao J (2022) More than just a periodontal pathogen -the research progress on Fusobacterium nucleatum. Front Cell Infect Microbiol 12:815318. https://doi.org/10.3389/fcimb.2022.815318
doi: 10.3389/fcimb.2022.815318
pubmed: 35186795
pmcid: 8851061
Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22:299–306. https://doi.org/10.1101/gr.126516.111
doi: 10.1101/gr.126516.111
pubmed: 22009989
pmcid: 3266037
Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE (2001) Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother 45:1238–1243. https://doi.org/10.1128/AAC.45.4.1238-1243.2001
doi: 10.1128/AAC.45.4.1238-1243.2001
pubmed: 11257040
pmcid: 90449
Teng LJ, Hsueh PR, Tsai JC, Liaw SJ, Ho SW, Luh KT (2002) High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob Agents Chemother 46:2908–2913. https://doi.org/10.1128/AAC.46.9.2908-2913.2002
doi: 10.1128/AAC.46.9.2908-2913.2002
pubmed: 12183246
pmcid: 127412
Kim M, Yun SY, Lee Y, Lee H, Yong D, Lee K (2022) Clinical differences in patients infected with Fusobacterium and antimicrobial susceptibility of Fusobacterium isolates recovered at a tertiary-care hospital in Korea. Ann Lab Med 42:188–195. https://doi.org/10.3343/alm.2022.42.2.188
doi: 10.3343/alm.2022.42.2.188
pubmed: 34635612
pmcid: 8548237
Kajihara T, Yahara K, Kitamura N, Hirabayashi A, Hosaka Y, Sugai M (2023) Distribution, trends, and antimicrobial susceptibility of Bacteroides, Clostridium, Fusobacterium, and Prevotella species causing bacteremia in Japan during 2011–2020: a retrospective observational study based on national surveillance data. Open Forum Infect Dis 10:ofad334. https://doi.org/10.1093/ofid/ofad334
doi: 10.1093/ofid/ofad334
pubmed: 37469615
pmcid: 10352651
CLSI (2023) CLSI M100-ED33:2023 Performance standards for antimicrobial susceptibility testing, 33rd ed. Clinical and Laboratory Standards Institute. em100.edaptivedocs.net/GetDoc.aspx?doc=CLSI%20M100%20ED33:2023&scope=user. Accessed 18 September 2023
Kwong TNY, Wang X, Nakatsu G, Chow TC, Tipoe T, Dai RZW, Tsoi KKK, Wong MCS, Tse G, Chan MTV, Chan FKL, Ng SC, Wu JCY, Wu WKK, Yu J, Sung JJY, Wong SH (2018) Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer. Gastroenterology 155:383-390.e8. https://doi.org/10.1053/j.gastro.2018.04.028
doi: 10.1053/j.gastro.2018.04.028
pubmed: 29729257
Yamaoka Y, Suehiro Y, Hashimoto S, Hoshida T, Fujimoto M, Watanabe M, Imanaga D, Sakai K, Matsumoto T, Nishioka M, Takami T, Suzuki N, Hazama S, Nagano H, Sakaida I, Yamasaki T (2018) Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population. J Gastroenterol 53:517–524. https://doi.org/10.1007/s00535-017-1382-6
doi: 10.1007/s00535-017-1382-6
pubmed: 28823057
Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14:195–206. https://doi.org/10.1016/j.chom.2013.07.012
doi: 10.1016/j.chom.2013.07.012
pubmed: 23954158
pmcid: 3770529
Lee SJ, Baek YJ, Kim JN, Lee KH, Lee EH, Yeom JS, Choi JY, Ku NS, Ahn JY, Kim JH, Jeong SJ (2022) Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogen. PLoS One 17:e0266610. https://doi.org/10.1371/journal.pone.0266610
doi: 10.1371/journal.pone.0266610
pubmed: 35421136
pmcid: 9009667
Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N (2003) Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52:79–83. https://doi.org/10.1136/gut.52.1.79
doi: 10.1136/gut.52.1.79
pubmed: 12477765
pmcid: 1773498
Vidaurrazaga MM, McKinley GF, Camins BC (2020) Postpartum Fusobacterium gonidiaformans bacteremia. Anaerobe 62:102168. https://doi.org/10.1016/j.anaerobe.2020.102168
doi: 10.1016/j.anaerobe.2020.102168
pubmed: 32045837
Tena D, Losa C, Medina-Pascual MJ, Sáez-Nieto JA (2014) Fournier’s gangrene caused by Actinomyces funkei, Fusobacterium gonidiaformans and Clostridium hathewayi. Anaerobe 27:14–16. https://doi.org/10.1016/j.anaerobe.2014.02.004
doi: 10.1016/j.anaerobe.2014.02.004
pubmed: 24631671
Stavreas NP, Amanatidou CD, Hatzimanolis EG, Legakis I, Naoum G, Lakka-Papadodima E, Georgoulias G, Morfou P, Tsiodras S (2005) Thyroid abscess due to a mixed anaerobic infection with Fusobacterium mortiferum. J Clin Microbiol 43:6202–6204. https://doi.org/10.1128/JCM.43.12.6202-6204.2005
doi: 10.1128/JCM.43.12.6202-6204.2005
pubmed: 16333131
pmcid: 1317160
Matsukawa Y, Kitamura N, Kaneko M, Yoshioka D, Miki T, Nishinarita S, Horie T, Hosokawa N, Iwasaki Y, Kumasaka K, Kawano K (2003) Multibacterial sepsis in an alcohol abuser with hepatic cirrhosis. Intern Med 42:208–210. https://doi.org/10.2169/internalmedicine.42.208
doi: 10.2169/internalmedicine.42.208
pubmed: 12636245
Ullrich E, Grisold AJ, Feierl G, Lumenta DB, Leitner E (2016) Severe forefoot infection complicated by Fusobacterium russii. Anaerobe 42:162–165. https://doi.org/10.1016/j.anaerobe.2016.10.010
doi: 10.1016/j.anaerobe.2016.10.010
pubmed: 27789247
Schuetz AN (2014) Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis 59:698–705. https://doi.org/10.1093/cid/ciu395
doi: 10.1093/cid/ciu395
pubmed: 24867792
Könönen E, Conrads G, Nagy E (2015) Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic gram-negative rods. Manual of clinical microbiology. ASM Press, Washington, DC, pp 967–993
Reissier S, Penven M, Guérin F, Cattoir V (2023) Recent trends in antimicrobial resistance among anaerobic clinical isolates. Microorganisms 11:1474. https://doi.org/10.3390/microorganisms11061474
doi: 10.3390/microorganisms11061474
pubmed: 37374976
pmcid: 10302625